|
|
|
|
| LEADER |
02205nam a2200265 u 4500 |
| 001 |
EB002072143 |
| 003 |
EBX01000000000000001212233 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
220923 r ||| eng |
| 020 |
|
|
|a 9780309269452
|
| 020 |
|
|
|a 0309269458
|
| 100 |
1 |
|
|a Palmer, Guy
|e [editor]
|
| 245 |
0 |
0 |
|a Combating antimicrobial resistance and protecting the miracle of modern medicine
|h Elektronische Ressource
|c Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
|
| 260 |
|
|
|a Washington, DC
|b National Academies Press
|c 2022, [2022]
|
| 300 |
|
|
|a 1 PDF file (xxviii, 365 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a Buckley, Gillian J.
|e [editor]
|
| 710 |
2 |
|
|a National Academies of Sciences, Engineering, and Medicine (U.S.)
|b Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Consensus study report of the National Academies of Sciences, Engineering, Medicine
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK574712
|3 Volltext
|
| 082 |
0 |
|
|a 363
|
| 520 |
|
|
|a Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market
|